Carol Halloran
Scripps Research Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Carol Halloran.
British Journal of Haematology | 2001
Pauline Lee; Carol Halloran; Reneé Trevino; Vincent J. Felitti; Ernest Beutler
Numerous polymorphisms of the transferrin gene result in a range of electrophoretic variants. We show that one of these mutations has a functional consequence. A G→A mutation at cDNA nucleotide 829 (G277S) was associated with a reduction in total iron binding capacity (TIBC). In menstruating white women, the G277S genotype was a risk factor for iron deficiency anaemia: iron deficiency anaemia was present in 27% of homozygous G277S/G277S women, 10% of G277G/G277S heterozygous women and 5% of homozygous wild‐type G277G/G277G women.
Movement Disorders | 2002
Pauline Lee; Terri Gelbart; Carol West; Carol Halloran; Jack C. Sipe; Ernest Beutler
Mice with targeted disruptions in the iron‐responsive binding protein 2 (IRP2) gene accumulate iron in distinct regions of the brain and develop neurodegenerative characteristics resembling Parkinsons disease after 6 months of age. To determine whether polymorphisms in IRP2 predispose humans to Parkinsons disease (PD), we sequenced the IRP2 gene of subjects with sporadic PD and normal controls. Three polymorphisms which result in an amino acid change were identified: L159V, F272L, and T560I. The L159V and T560I polymorphisms, identified in an African‐American PD subject, were found in the African‐American population at an allele frequency of 0.102 (n = 1,236) and 0.111 (n = 1,228), respectively, and were not associated with an increased prevalence of PD. The F272L polymorphism was found in a normal 58‐year‐old, Caucasian subject whose father had PD, but it was not observed in 38 additional patients with sporadic PD. The F272L polymorphism occurred at an allele frequency of 0.0014 (n = 1,384) in the normal Caucasian population. Additional F272L heterozygous subjects identified in the normal population did not have a family or personal history of PD. We conclude that these IRP2 polymorphisms do not play an important role in the development of sporadic cases of PD. It remains to be determined whether other polymorphisms in IRP2 play a role in familial PD.
Blood Cells Molecules and Diseases | 1998
Pauline Lee; Terri Gelbart; Carol West; Carol Halloran; Ernest Beutler
Blood Cells Molecules and Diseases | 2001
Pauline Lee; Terri Gelbart; Carol West; Carol Halloran; Vincent J. Felitti; Ernest Beutler
Blood Cells Molecules and Diseases | 2002
Pauline Lee; Terri Gelbart; Carol West; Carol Halloran; Ernest Beutler
Journal of Biological Chemistry | 1991
Ron D. Bowditch; Carol Halloran; Shin Ichi Aota; Masanobu Obara; Edward F. Plow; Kenneth M. Yamada; Mark H. Ginsberg
Journal of Biological Chemistry | 1996
Joseph C. Loftus; Carol Halloran; Mark H. Ginsberg; Larry P. Feigen; Jeffery Alan Zablocki; Jeffrey W. Smith
Blood Cells Molecules and Diseases | 2001
Pauline Lee; Carol Halloran; Carol West; Ernest Beutler
Blood Cells Molecules and Diseases | 2001
Pauline Lee; Carol Halloran; Ernest Beutler
Biochemical and Biophysical Research Communications | 2000
Pauline Lee; Carol Halloran; Andrew R. Cross; Ernest Beutler